Inventor · disambiguated record
Laurence Patterson
Also filed as: PATTERSON LAURENCE · PATTERSON LAURENCE H · PATTERSON LAURENCE HYLTON
29 granted patents·4 pending applications·123 citations·filing 1990–2020
95Inventor score
Top patents by PatentIndex Score
33 records- 0190US5132327AAnti-cancer compoundsNAT RES DEV·Filed 1990·Granted Jul 21, 1992·37 cites·13 claims
- 0287US7723085B2Analyzing cells immobilized in block copolymersBIOSTATUS LTD·Filed 2005·Granted May 25, 2010·10 cites·28 claims
- 0385US6468753B1Anthraquinone and its derivativesBIOSTATUS LTD·Filed 1999·Granted Oct 22, 2002·22 cites·17 claims
- 0480US9358303B2Compounds containing a vascular disrupting agentINCANTHERA LTD·Filed 2013·Granted Jun 7, 2016·5 cites·17 claims
- 0577US9956296B2Compounds containing a vascular disrupting agentINCANTHERA LTD·Filed 2016·Granted May 1, 2018·2 cites·18 claims
- 0677US8691751B2Compounds containing a vascular disrupting agentGILL JASON·Filed 2008·Granted Apr 8, 2014·6 cites·21 claims
- 0776US8927486B2CompoundsFALCONER ROBERT·Filed 2009·Granted Jan 6, 2015·4 cites·24 claims
- 0875US11266613B2Lidocaine n-oxide for use in the prophylaxis of sudden cardiac deathBIOTHERICS LTD·Filed 2018·Granted Mar 8, 2022·1 cites·20 claims
- 0975US7605280B2Anthraquinone and its derivativesBIOSTATUS LTD·Filed 2006·Granted Oct 20, 2009·2 cites·16 claims
- 1075US7276537B2Formulations of anthraquinone derivativesBTG INT LTD·Filed 2006·Granted Oct 2, 2007·3 cites·14 claims
- 1173US7060427B2Anthraquinone and its derivativesBIOSTATUS LTD·Filed 2002·Granted Jun 13, 2006·8 cites·9 claims
- 1272US9937267B2Methods of treating cancer using compounds containing a vascular disrupting agentINCANTHERA LTD·Filed 2016·Granted Apr 10, 2018·1 cites·28 claims
- 1371US9759715B2Gel formulations and uses thereofSMITH PAUL·Filed 2010·Granted Sep 12, 2017·1 cites·25 claims
- 1466US2020316212A1Methods of treating cancer using compounds containing a vascular disrupting agentELLIPSES PHARMA LTD·Filed 2020·Application pending·0 cites
- 1564US11401234B2Deuterated compounds and uses thereofBIOSTATUS LTD·Filed 2019·Granted Aug 2, 2022·0 cites·41 claims
- 1663US10912839B2Methods of treating cancer using compounds containing a vascular disrupting agentELLIPSES PHARMA LTD·Filed 2018·Granted Feb 9, 2021·0 cites·25 claims
- 1762US8017640B2Benz-indole and benzo-quinoline derivatives as prodrugs for tumor treatmentUNIV BRADFORD·Filed 2007·Granted Sep 13, 2011·0 cites·20 claims
- 1862US7626026B2Pyrrolo-indole and pyrrolo-quinoline derivatives as prodrugs for tumour treatmentUNIV BRADFORD·Filed 2002·Granted Dec 1, 2009·2 cites·12 claims
- 1960US10556014B2Compounds containing a vascular disrupting agentINCANTHERA LTD·Filed 2018·Granted Feb 11, 2020·0 cites·24 claims
- 2060US2015196658A1CompoundsINCANTHERA LTD·Filed 2014·Application pending·0 cites
- 2158US7074835B2Formulations of anthraquinone derivativesBTG INT LTD·Filed 2003·Granted Jul 11, 2006·2 cites·18 claims
- 2254US11255761B2Method of analysing a cell or other biological material containing a nucleic acidBIOSTATUS LTD·Filed 2015·Granted Feb 22, 2022·0 cites·17 claims
- 2354US9051467B2Method of analysing a cell or other biological material containing a nucleic acidSMITH PAUL JAMES·Filed 2011·Granted Jun 9, 2015·0 cites·18 claims
- 2450US10385009B2Deuterated compounds and uses thereofBIOSTATUS LTD·Filed 2013·Granted Aug 20, 2019·0 cites·34 claims
- 2548US5461078AAnti-cancer compoundsBRITISH TECH GROUP·Filed 1992·Granted Oct 24, 1995·3 cites·10 claims
- 2645US2007208085A1Potent cytotoxicity and inhibition of pan-cell cycle progression by an alkylating anthraquinoneSOMANTA LTD·Filed 2007·Application pending·0 cites
- 2744US7179921B2Indoline and tetrahydro-quinolines as prodrugs for tumour treatmentUNIV LONDON PHARMACY·Filed 2002·Granted Feb 20, 2007·0 cites·8 claims
- 2843US7192977B2Benz-indole and benzo-quinoline derivatives as prodrugs for tumor treatmentUNIV LONDON PHARMACY·Filed 2002·Granted Mar 20, 2007·0 cites·59 claims
- 2940US5447950AAnthra[1,9-c,d]pyrazol-6-(2H)-ones useful for treating anaerobic bacterial infectionsBRITISH TECH GROUP·Filed 1993·Granted Sep 5, 1995·3 cites·12 claims
- 3039US6465522B1Anthraquinone anticancer drugsMONTFORD UNIVERSITY DE·Filed 1999·Granted Oct 15, 2002·11 cites·15 claims
- 3138US2009233966A1Analogues of the Azinomycins as Anti-Tumour Agents and as ProdrugsUNIV LONDON PHARMACY·Filed 2006·Application pending·0 cites
- 3236US11447638B2Acetalanthraquinone derivatives useful for cellular stainingBIOSTATUS LTD·Filed 2017·Granted Sep 20, 2022·0 cites·27 claims
- 3333US7557215B2Anthraquinone compounds as anti cancer compoundsSOMANTA LTD·Filed 2004·Granted Jul 7, 2009·0 cites·24 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →